Blood Factor Program

Blood Factor Program

The Massachusetts General Hospital Blood Factor Program was established as a non-profit factor home delivery service in 2014. Revenue generated through our Blood Factor Pharmacy Program have played an important role in the growth of our HTC clinical staff, creating more opportunities to support our patients and expand our services to our community. We have partnered with New England Life Care as our preferred Blood Factor Contract Pharmacy.

Our Blood Factor Program allows our clinical staff the ability to ship blood factor products directly to our patient’s home, conveniently and effectively. This model enables our team to more oversight into getting our patients their medication. Our team handles all eligibility determinations, prior authorizations, deliveries, blood factor management, billing and can troubleshoot any issues patients may experience quickly.

Our Blood Factor Program is an elective program to join by our patients. Patients are free to use whichever pharmacy service they are most comfortable using. Eligibility for our program is performed by our billing staff through a thorough process of determining where each patients Blood Factor coverage lies within their plan. All plans have both a pharmacy benefit and a medical benefit, in which we must determine where your in-home blood factor injectable coverage is found.

Services We Provide

Our clinical team believes our Factor Program provides services that are as good and, in most cases, better than those provided by large for-profit, home-delivery pharmacies and home-care companies. We have a fully integrated staff of pharmacist’s who work closely with our clinical, administrative and billing teams. We work collaboratively to solve all customer service issues our patients encounter in an efficient manner.

Below are a list of services included in our Blood Factor Program:

• Home delivery
• Access to all blood factor treatments
• Expansive selection of infusion supplies
• Support for the cost of home infusion nursing services and coordinating visits for patients
• Attentive customer service
• Ongoing clarification of insurance coverage for factor waste disposal program
• Patient Education Programs
• 24-hour phone contact

340B and Why It's Important

Under Section 340B of the Public Health Service Act, drug manufacturers that participate in Medicaid must offer outpatient medications at reduced prices to certain types of health care organizations that serve either low-income or uninsured patients. One of the health care organizations or covered entities this pertains to are HTCs, or hemophilia treatment centers. 340B generated funds allow our HTC to stretch limited federal resources to reduce the price of outpatient pharmaceuticals for patients and expand health services to the patients and communities we serve. These savings are passed on to the patient directly in terms of discounted prices of incredibly expensive medications passed on to their insurance company.

Manufacturing Co-pay Assistance Programs

All manufacturers of Blood Factor products have Co-pay Assistance programs all patients can and should enroll in. The Co-pay Assistance programs are tremendously beneficial as they can be utilized to cover Premiums and Deductibles on plans.

As we know, Blood Factor is tremendously expensive. On January 1, your deductible is reset. You may have $5,000 deductible. If on January 2 you are shipped your Monthly Blood Factor medication, your deductible will be met on that shipment. The Co-pay Assistance Program is designed knowing the great expense of the medication, to allow you to pay your deductibles with their Co-pay Assistance Programs.